טוען...
An HIV Vaccine for South-East Asia—Opportunities and Challenges
Recent advances in HIV vaccine development along with a better understanding of the immune correlates of risk have emerged from the RV144 efficacy trial conducted in Thailand. Epidemiological data suggest that CRF01_AE is still predominant in South-East Asia and is spreading in China with a growing...
שמור ב:
| הוצא לאור ב: | Vaccines (Basel) |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4494230/ https://ncbi.nlm.nih.gov/pubmed/26344118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines1030348 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|